Glycaemic control in type 2 patients starting insulin therapy - a retrospective study

被引：0
|
作者：
Smith, I. C.
Richards, N.
Compion, G. H.
机构：
[1] Novo Nordisk UK, Pricing & Hlth Econ Unit, Crawley, England
[2] CompuFile Ltd, Surrey, England
[3] Novo Nordisk AS, Med Informat, Crawley, England
来源：
DIABETOLOGIA | 2006年 / 49卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
0400
引用
收藏
页码：246 / 246
页数：1
相关论文
共 50 条
  • [21] Insulin glargine-based therapy improves glycaemic control in patients with type 2 diabetes suboptimally controlled on premixed insulin therapies
    Storms, F.
    Davies, M.
    Gomis, R.
    DIABETOLOGIA, 2006, 49 : 600 - 601
  • [22] Worse glycaemic control in LADA patients than in those with type 2 diabetes, despite a longer time on insulin therapy
    Andersen, C. D.
    Bennet, L.
    Nystrom, L.
    Lindblad, U.
    Lindholm, E.
    Groop, L.
    Rolandsson, O.
    DIABETOLOGIA, 2013, 56 (02) : 252 - 258
  • [23] Worse glycaemic control in LADA patients than in those with type 2 diabetes, despite a longer time on insulin therapy
    C. D. Andersen
    L. Bennet
    L. Nyström
    U. Lindblad
    E. Lindholm
    L. Groop
    O. Rolandsson
    Diabetologia, 2013, 56 : 252 - 258
  • [24] Is it worthwhile adding glitazone therapy to insulin-treated Type 2 patients in poor glycaemic control? A prospective audit
    Levy, D.
    Liew, L.
    Barron, B.
    Manogaraan, B.
    Reilly, P.
    DIABETIC MEDICINE, 2007, 24 : 66 - 66
  • [25] Starting insulin in type 2 diabetes: Overcoming barriers to insulin therapy
    Kabadi, Udaya M.
    INTERNATIONAL JOURNAL OF DIABETES IN DEVELOPING COUNTRIES, 2008, 28 (02) : 65 - 68
  • [26] Dapagliflozin improves glycaemic control in insulin-resistant patients with type 2 diabetes
    Wilding, J. P. H.
    Norwood, P.
    T'joen, C.
    Bastien, A.
    List, J. F.
    Fiedorek, F. T.
    DIABETOLOGIA, 2009, 52 : S76 - S76
  • [27] Acarbose improves glycaemic control in patients with insulin - Treated type 2 diabetes.
    Simpson, H
    Robertson-Mackay, F
    Montegriffo, E
    Fox, C
    DIABETOLOGIA, 1999, 42 : A223 - A223
  • [28] Implementation of intensive insulin therapy improves glycaemic control in patients managed with conventional insulin therapy
    C Krieger
    G Dempsey
    T Jones
    Critical Care, 9 (Suppl 1):
  • [29] Glycaemic Control of Type 2 Diabetics with Insulin Glargine in Everyday Practice Type 2 diabetic patients poorly controlled on insulin detemir therapy benefit from switching to insulin glargine
    Lieverse, A. G.
    Rodriguez, M.
    Czupryniak, L.
    Landgraf, W.
    Loizeau, V.
    Pilorget, V.
    Dain, M. -P.
    Kvapil, M.
    DIABETES STOFFWECHSEL UND HERZ, 2013, 22 (03): : 141 - 147
  • [30] Impact of linagliptin therapy in patients with Type 2 diabetes and suboptimal glycaemic control
    Holland, A. L.
    Gururaj, S.
    Lawrence, I.
    DIABETIC MEDICINE, 2014, 31 : 182 - 183
12345